| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |